Back to search
FDAFDA · Food and drugs·Recall number D-0340-2026

Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.

Published February 18, 2026 · Recall initiated: February 9, 2026

Summary

FDA records drug Class II recall D-0340-2026, published February 18, 2026 and initiated February 9, 2026. Recalling firm: Meitheal Pharmaceuticals, Inc; Status: Ongoing; Reported quantity: 16,477 kits; Lot: Lot Q4E0112A, Exp.: 30 Apr 2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: Missing or duplicated needles within the injection kit

What to do

Voluntary: Firm initiated · Letter

Get an email if CETRORELIX ACETATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CETRORELIX ACETATE
Manufacturer
Meitheal Pharmaceuticals, Inc
Distributor
U.S. Nationwide
Lot
Lot Q4E0112A, Exp.: 30 Apr 2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90. recalled?

Yes. FDA published recall D-0340-2026 on February 18, 2026. Reported hazard: Defective Delivery System: Missing or duplicated needles within the injection kit

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CETRORELIX ACETATE.